Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information


Currently viewing:

Administrative data

Description of key information

No carcinogenicity study is available for tert.-Butylperoxy- 2-ethylhexanoat.
Annex X, Column 2, Sect. 8.9.1 of the REACh Regulation states as follows:
"A carcinogenicity study may be proposed by the registrant or may be required by the Agency in accordance with Articles 40 or 41 if:
- the substance has a widespread dispersive use or there is evidence of frequent or long-term human exposure, and
- the substance is classified as mutagen category 3 or there is evidence from the repeated dose study(ies) that the substance is able to induce hyperplasia and/or pre-neoplastic lesions.
If the substance is classified as mutagen category 1 or 2, the default presumption would be that a genotoxic mechanism for carcinogenicity is likely. In these cases, a carcinogenicity test will normally not required. "

Tert.-Butylperoxy- 2-ethylhexanoat has no widespread use and tert.-Butylperoxy- 2-ethylhexanoat showed no indication for mutagen effects in vivo. A carcinogenicity study could not be justified scientifically and not in line with animal welfare. The need of conducting a study will be reconsidered in case of preneoplastic lesions observations after completion of the 90-day study.

Key value for chemical safety assessment

Justification for classification or non-classification

Additional information